Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

NCT01105208 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Infective Agents

Interventions

DRUG: Cephalexin suspension (Optocef, BAYO5448 )
DRUG: Cephalexin suspension (Keflex)

Sponsor

Bayer

Collaborators

[object Object]